Clinical significance of radiologic characterizations in COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 6, Issue 6, 2009, Pages 459-467

  Han, Meilan K ^a   Bartholmai, Brian ^b   Liu, Lyrica X ^a   Murray, Susan ^a   Curtis, Jeffrey L ^a,c   Sciurba, Frank C ^d   Kazerooni, Ella A ^a   Thompson, Bruce ^e   Frederick, Margaret ^f   Li, Daner ^f   Schwarz, Marvin ^g   Limper, Andrew ^b   Freeman, Christine ^a   Landreneau, Rodney J ^d   Wise, Robert ^h   Martinez, Fernando J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b Information Technology   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e Clinical Trials & Surveys Corp   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g Mayo Clinic   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

BODE; COPD; Exacerbation; HRCT; HRQL

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HEALTH STATUS; LUNG EMPHYSEMA; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING; VOLUMETRY;

AGE FACTORS; AGED; BODY MASS INDEX; COHORT STUDIES; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; PULMONARY GAS EXCHANGE; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 73549088517     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412550903341513     Document Type: Article

References (34)

1. Hogg J, Chu F, Utokaparch S, Woods R, Elliott W, Buzatu L, Cherniack R, Rogers R, Sciurba F, Coxson H, Pare P. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Eng J Med 2004; 350:2645-2653. (Pubitemid 38787999)
2. Hogg J. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364:709-721. (Pubitemid 39140629)
3. Aziz ZA, Wells AU, Desai SR, Ellis SM, Walker AE, MacDonald S, Hansell DM. Functional impairment in emphysema: Contribution of airway abnormalities and distribution of parenchymal disease. Am J Roentgenol 2005; 185:1509-1515.
4. Cerveri I, Dore R, Corsico A, Zoia MC, Pellegrino R, Brusasco V, Pozzi E. Assessment of emphysema in COPD: A functional and radiologic study. Chest 2004; 125:1714-1718.
5. Fujimoto K, Kitaguchi Y, Kubo K, Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology 2006; 11:731-740.
6. Hasegawa M, Nasuhara Y, Onodera Y, Makita H, Nagai K, Fuke S, Ito Y, Betsuyaku T, Nishimura M. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:1309-1315.
7. Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of copd phenotypes classified according to the findings of hrct. Respir Med 100:1742-1752.
8. Makita H, Nasuhara Y, Nagai K, Ito Y, Hasegawa M, Betsuyaku T, Onodera Y, Hizawa N, Nishimura M, the Hokkaido COPD Cohort Study Group. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax 2007; 62:932-937.
9. Pistolesi M, Camiciottoli G, Paoletti M, Marmai C, Lavorini F, Meoni E, Marchesi C, Giuntini C. Identification of a predominant copd phenotype in clinical practice. Respir Med 2008; 102:367-376.
10. Boschetto P, Quintavalle S, Zeni E, Leprotti S, Potena A, Ballerin L, Papi A, Palladini G, Luisetti M, Annovazzi L, Iadarola P, De Rosa E, Fabbri LM, Mapp CE. Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax 2006; 61:1037-1042. (Pubitemid 44852020)
11. Celli B, Calverley P, Rennard S, Wouters E, Agusti A, Anthonisen N, MacNeeW, Jones P, Pride N, Rodrigues-Roisin R, Rossi R, Wanner A. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease. Respir Med 2005; 99:1546-1554. (Pubitemid 41683935)
12. Celli B, Cote C, Marin J, Casanova C, Montes de Oca M, Mendez R, Pinto-Plata V, Cabral H. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Eng J Med 2004; 350:1005-1012.
13. Brooks S. Surveillance for respiratory hazards. ATS News 1982; 8:12-16.
14. Comstock GW, Tockman MS, Helsing KJ, Hennesy KM. Standardized respiratory questionnaires: Comparison of the old with the new. Am Rev Respir Dis 1979; 119:45-53.
15. Sciurba F, Criner G, Lee S, Mohsenifar Z, Shade D, Slivka W, Wise R, for the National Emphysema Treatment Trial Research Group. Six-minute walk distance in chronic obstructive pulmonary disease. Reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med 2003; 167:1522-1527.
16. Orlandi I, Moroni C, Camiciottoli G, Bartolucci M, Pistolesi M, Villari N, Mascalchi M. Chronic obstructive pulmonary disease: Thin-section ct measurement of airway wall thickness and lung attenuation. Radiology 2005; 234:604-610.
17. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, Itoh H, Pare PD, Hogg JC, Mishima M. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000; 162:1102-1108.
18. Brasfield D, Hicks G, Soong S, Peters J, Tiller R. Evaluation of scoring system of the chest radiograph in cystic fibrosis: A collaborative study. AJR Am J Roentgenol 1980; 134:1195-1198.
19. Ogawa E, Nakano Y, Ohara T, Muro S, Hirai T, Sato S, Sakai H, Tsukino M, Kinose D, Nishioka M, Niimi A, Chin K, Pare PD, Mishima M. Body mass index in male patients with copd: Correlation with low attenuation areas on ct. Thorax 2009; 64:20-25.
20. O'Donnell D, Revill S, Webb K. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care 2001; 164:770-777.
21. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN,Wilson J, Leader JK, Siegfried JM, Shapiro SD, Sciurba FC. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008; 178:738-744.
22. McAllister DA, Maclay JD, Mills NL, Mair G, Miller J, Anderson D, Newby DE, Murchison JT, Macnee W. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176:1208-1214.
23. Martinez F, FosterG, Curtis J, CrinerG,WeinmannG, Fishman A, DeCamp M, Benditt J, Sciurba F, Make B, Mohsenifar Z, Diaz P, Hoffman E, Wise R, for the NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173:1326-1334.
24. Burrows B, Bloom J, Traver G, Cline M. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317:1309-1314.
25. Reid L. Measurement of the bronchial mucous gland layer: A diagnostic yardstick in chronic bronchitis. Thorax 1960; 15:132-141.
26. Nakano Y, Wong J, de Jong P, Buzatu L, Nagao T, Coxson H, Elliott W, Hogg J, Pare P. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005;171:142-146.
27. Jones P. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56:880-887. (Pubitemid 32999838)
28. Kaplan R, Ries A, Reilly J, Mohsenifar Z. Measurement of health-related quality of life in the national emphysema treatment trial. Chest 2004; 126:781-789.
29. Miniati M, Monti S, Stolk J, Mirarchi G, Falaschi F, Rabinovich R, Canapini C, Roca J, Rabe KF. Value of chest radiography in phenotyping chronic obstructive pulmonary disease. Eur Respir J 2008; 31:509-515.
30. Carrasco Garrido P, de Miguel Diez J, Rejas Gutierrez J, Centeno AM, Gobartt Vazquez E, Gil de Miguel A, Garcia Carballo M, Jimenez Garcia R. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the epidepoc study. Health Qual Life Outcomes 2006; 4:31.
31. Seemungal T, Donaldson G, Paul E, Bestall J, Jeffries D, Wedzicha J. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1418-1422.
32. Seemungal T, Donaldson G, Bhowmik A, Jeffries D, Wedzicha J. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1608-1613. (Pubitemid 30329036)
33. Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med 2008; 177:396-401. (Pubitemid 351317582)
34. Conte ME, Pedone C, Forastiere F, Bellia V, Antonelli-Incalzi R. Discriminative and predictive properties of disease-specific and generic health status indexes in elderly copd patients. BMC Pulm Med 2008; 8:14.